BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37761808)

  • 21. Genetic Profiling of Primary Orbital Melanoma: An Analysis of 6 Cases with Clinicopathologic Correlation.
    Mudhar HS; Doherty RE; Salvi SM; Currie ZI; Tan JH; Sisley K
    Ophthalmology; 2019 Jul; 126(7):1045-1052. PubMed ID: 30605742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Characteristics of Conjunctival Melanoma Using Whole-Exome Sequencing.
    Swaminathan SS; Field MG; Sant D; Wang G; Galor A; Dubovy SR; Harbour JW; Karp CL
    JAMA Ophthalmol; 2017 Dec; 135(12):1434-1437. PubMed ID: 29121185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
    Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics.
    Cirenajwis H; Lauss M; Ekedahl H; Törngren T; Kvist A; Saal LH; Olsson H; Staaf J; Carneiro A; Ingvar C; Harbst K; Hayward NK; Jönsson G
    Mol Oncol; 2017 Apr; 11(4):438-451. PubMed ID: 28267273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic drivers of non-cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape.
    Vergara IA; Wilmott JS; Long GV; Scolyer RA
    Exp Dermatol; 2022 Jan; 31(1):13-30. PubMed ID: 33455025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
    Brouwer NJ; Konstantinou EK; Gragoudas ES; Marinkovic M; Luyten GPM; Kim IK; Jager MJ; Vavvas DG
    Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):3. PubMed ID: 33798262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.
    Lodde GC; Jansen P; Möller I; Sucker A; Hassel JC; Forschner A; Eckardt J; Meier F; Reinhardt L; Kähler KC; Ziemer M; Schlaak M; Rahimi F; Schatton K; Meiss F; Gutzmer R; Pföhler C; Terheyden P; Schilling B; Sachse M; Heppt MV; Sindrilaru A; Leiter U; Zaremba A; Thielmann CM; Ugurel S; Zimmer L; Hadaschik E; Bechrakis NE; Schadendorf D; Westekemper H; Livingstone E; Griewank KG;
    Eur J Cancer; 2022 May; 166():60-72. PubMed ID: 35279471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of distinct molecular profile of Primary Dermal Melanoma.
    Shaigany S; Tessier-Cloutier B; Busam KJ; Horst BA
    Hum Pathol; 2020 Dec; 106():32-38. PubMed ID: 32946880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and clinico-pathologic analysis of metastatic uveal melanoma.
    Griewank KG; van de Nes J; Schilling B; Moll I; Sucker A; Kakavand H; Haydu LE; Asher M; Zimmer L; Hillen U; Thompson JF; Scolyer RA; Schadendorf D; Murali R
    Mod Pathol; 2014 Feb; 27(2):175-83. PubMed ID: 23887304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
    Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
    Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis.
    Rose AM; Luo R; Radia UK; Kalirai H; Thornton S; Luthert PJ; Jayasena CN; Verity DH; Coupland SE; Rose GE
    BMC Cancer; 2018 Dec; 18(1):1262. PubMed ID: 30558566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
    Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
    Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature.
    Chłopek M; Lasota J; Thompson LDR; Szczepaniak M; Kuźniacka A; Hińcza K; Kubicka K; Kaczorowski M; Newford M; Liu Y; Agaimy A; Biernat W; Durzyńska M; Dziuba I; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kato H; Kopczyński J; Michal M; Michal M; Pęksa R; Prochorec-Sobieszek M; Starzyńska A; Takahashi S; Wasąg B; Kowalik A; Miettinen M
    Mod Pathol; 2022 Nov; 35(11):1609-1617. PubMed ID: 35978013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.
    Newell F; Kong Y; Wilmott JS; Johansson PA; Ferguson PM; Cui C; Li Z; Kazakoff SH; Burke H; Dodds TJ; Patch AM; Nones K; Tembe V; Shang P; van der Weyden L; Wong K; Holmes O; Lo S; Leonard C; Wood S; Xu Q; Rawson RV; Mukhopadhyay P; Dummer R; Levesque MP; Jönsson G; Wang X; Yeh I; Wu H; Joseph N; Bastian BC; Long GV; Spillane AJ; Shannon KF; Thompson JF; Saw RPM; Adams DJ; Si L; Pearson JV; Hayward NK; Waddell N; Mann GJ; Guo J; Scolyer RA
    Nat Commun; 2019 Jul; 10(1):3163. PubMed ID: 31320640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.
    Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP
    BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic Profiling of Metastatic Uveal Melanoma Shows Frequent Coexisting BAP1 or SF3B1 and GNAQ/GNA11 Mutations and Correlation With Prognosis.
    Isaacson AL; Sompallae RR; Guseva NV; Bellizzi AM; Bossler AD; Ma D
    Am J Clin Pathol; 2022 Aug; 158(2):177-186. PubMed ID: 35212356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes.
    Lake SL; Jmor F; Dopierala J; Taktak AF; Coupland SE; Damato BE
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5598-604. PubMed ID: 21693616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Management of Uveal and Conjunctival Melanoma.
    Blum ES; Yang J; Komatsubara KM; Carvajal RD
    Oncology (Williston Park); 2016 Jan; 30(1):29-32, 34-43, 48. PubMed ID: 26791842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.